Drug Profile
Research programme: anti inflammatory therapeutics - LTT Bio-Pharma
Alternative Names: LT-0201; NSAID - LTT Bio-pharmaLatest Information Update: 12 Oct 2018
Price :
$50
*
At a glance
- Originator LTT Bio-Pharma
- Class Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 12 Sep 2018 Pharmacodynamics data from a preclinical presented at the 17th World Congress on Pain (WCP-2018)
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in Japan
- 13 Aug 2015 LTT Bio-Pharma has international patent protection for lexoprofen derivatives